Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 3
2010 1
2011 2
2012 3
2013 1
2014 4
2015 3
2016 2
2017 1
2018 2
2019 1
2020 3
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

26 results
Results by year
Filters applied: . Clear all
Page 1
The Effect of Using Pazopanib With Food vs. Fasted on Pharmacokinetics, Patient Safety, and Preference (DIET Study).
Lubberman FJE, Gelderblom H, Hamberg P, Vervenne WL, Mulder SF, Jansman FGA, Colbers A, van der Graaf WTA, Burger DM, Luelmo S, Moes DJAR, van Herpen CML, van Erp NP. Lubberman FJE, et al. Among authors: mulder sf. Clin Pharmacol Ther. 2019 Nov;106(5):1076-1082. doi: 10.1002/cpt.1515. Epub 2019 Jul 9. Clin Pharmacol Ther. 2019. PMID: 31125423 Clinical Trial.
Real-world Data of Nivolumab for Patients With Advanced Renal Cell Carcinoma in the Netherlands: An Analysis of Toxicity, Efficacy, and Predictive Markers.
Verhaart SL, Abu-Ghanem Y, Mulder SF, Oosting S, Van Der Veldt A, Osanto S, Aarts MJB, Houtsma D, Peters FPJ, Groenewegen G, Van Herpen CML, Pronk LM, Tascilar M, Hamberg P, Los M, Vreugdenhil G, Polee M, Ten Tije AJ, Haanen JBAG, Bex A, van den Eertwegh AJ. Verhaart SL, et al. Among authors: mulder sf. Clin Genitourin Cancer. 2021 Jun;19(3):274.e1-274.e16. doi: 10.1016/j.clgc.2020.10.003. Epub 2020 Oct 14. Clin Genitourin Cancer. 2021. PMID: 33317946
Everolimus Exposure and Early Metabolic Response as Predictors of Treatment Outcomes in Breast Cancer Patients Treated with Everolimus and Exemestane.
Willemsen AECAB, de Geus-Oei LF, de Boer M, Tol J, Kamm Y, de Jong PC, Jonker MA, Vos AH, Grootjans W, de Groot JWB, Mulder SF, Aarntzen EHJG, Gerritsen WR, van Herpen CML, van Erp NP. Willemsen AECAB, et al. Among authors: mulder sf. Target Oncol. 2018 Oct;13(5):641-648. doi: 10.1007/s11523-018-0596-8. Target Oncol. 2018. PMID: 30259313
Severe exacerbation of Crohn's disease during sunitinib treatment.
Boers-Sonderen MJ, Mulder SF, Nagtegaal ID, Jacobs JF, Wanten GJ, Hoentjen F, van Herpen CM. Boers-Sonderen MJ, et al. Among authors: mulder sf. Eur J Gastroenterol Hepatol. 2014 Feb;26(2):234-6. doi: 10.1097/MEG.0b013e328365ac54. Eur J Gastroenterol Hepatol. 2014. PMID: 24025975
26 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page